Management of febrile neutropenia: ESMO Clinical Practice Guidelines
- PMID: 20555092
- DOI: 10.1093/annonc/mdq196
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
Similar articles
-
Risk assessment and risk-based therapy in febrile neutropenic patients.Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):461-3. doi: 10.1007/BF01691127. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9764547 No abstract available.
-
Initial management of febrile neutropenia for the primary provider: a summary of current practice guidelines.Hawaii Med J. 2008 Dec;67(12):333-4. Hawaii Med J. 2008. PMID: 19244707 No abstract available.
-
Out-patient management of febrile neutropenia.Int J Antimicrob Agents. 2000 Oct;16(2):169-71. doi: 10.1016/s0924-8579(00)00235-1. Int J Antimicrob Agents. 2000. PMID: 11053803 Review.
-
Ceftriaxone in febrile neutropenia.J Chemother. 2003 Jun;15(3):211-9. doi: 10.1179/joc.2003.15.3.211. J Chemother. 2003. PMID: 12868545 Review.
-
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres.Arch Dis Child. 2007 Jun;92(6):495-8. doi: 10.1136/adc.2006.102699. Epub 2007 Feb 6. Arch Dis Child. 2007. PMID: 17284481 Free PMC article.
Cited by
-
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study.Support Care Cancer. 2021 Oct;29(10):5905-5914. doi: 10.1007/s00520-021-06154-4. Epub 2021 Mar 24. Support Care Cancer. 2021. PMID: 33761002 Free PMC article.
-
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy.BMC Cancer. 2019 Feb 6;19(1):122. doi: 10.1186/s12885-019-5329-6. BMC Cancer. 2019. PMID: 30727980 Free PMC article. Clinical Trial.
-
Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT).Int J Hematol Oncol Stem Cell Res. 2013;7(4):1-9. Int J Hematol Oncol Stem Cell Res. 2013. PMID: 24505536 Free PMC article.
-
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.Target Oncol. 2021 Sep;16(5):553-568. doi: 10.1007/s11523-021-00824-3. Epub 2021 Jul 5. Target Oncol. 2021. PMID: 34224061 Free PMC article.
-
Infections in Cancer Patients with Solid Tumors: A Review.Infect Dis Ther. 2017 Mar;6(1):69-83. doi: 10.1007/s40121-017-0146-1. Epub 2017 Feb 3. Infect Dis Ther. 2017. PMID: 28160269 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical